Home > Insider Trading > Filing (0001179110-15-015767)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1005201	Depomed Inc	DEPO	Pharmaceutical Preparations (2834)	943229046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1344412	J August Moretti	C/O Depomed Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560	Chief Financial Officer & Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-12-01	7,329	$19.00	36,319	No	4	F	Direct
Common Stock	Disposition	2015-12-03	13,159	$18.12	23,160	No	4	S	Direct
Common Stock	Disposition	2015-12-03	1,841	$18.01	21,319	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock.
Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
The sales reported in this Form 4 were sold pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
The Common stock sold was acquired as part of a Restricted Stock Units (RSUs) award of 28,500 units granted on February 7, 2013. The RSUs vest over four years on December 1 of each year.
These shares form part of 1,867 shares acquired under the Company's ESPP and were purchased at $4.90 per share.